Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?
Hepat Mon
.
2013 Feb 20;13(2):e7560.
doi: 10.5812/hepatmon.7560.
Print 2013 Feb.
Author
Giovanni Tarantino
1
Affiliation
1
Department of Clinical and Experimental Medicine, School of Naples, Federico II University Medical, Naples, Italy.
PMID:
23610586
PMCID:
PMC3631528
DOI:
10.5812/hepatmon.7560
No abstract available
Keywords:
Biological Markers; Histology; Liver.